Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / ADR
-
Total 13F shares
-
5,912
-
Share change
-
+3,811
-
Total reported value
-
$289,935
-
Price per share
-
$49.04
-
Number of holders
-
5
-
Value change
-
+$189,714
-
Number of buys
-
1
-
Number of sells
-
1
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q4 2025
As of 31 Dec 2025,
GLAXOSMITHKLINE PLC - ADR (GSK) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,912 shares.
The largest 5 holders included
EADS & HEALD WEALTH MANAGEMENT, PARADIGM ASSET MANAGEMENT CO LLC, Asset Planning,Inc, Byrne Asset Management LLC, and HUNTINGTON NATIONAL BANK.
This page lists
5
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.